| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
2 companies
Bowden Christopher is a Director at TCRT with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $639K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2017 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 6,000 | $65.00 | $390,000.00 | -87.2% | |
| Jun 1, 2015 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 5,000 | $120.67 | $603,350.00 | -100% |